ARTICLE | Company News
Kissei Pharmaceutical metabolic, cardiovascular news
April 15, 2013 7:00 AM UTC
Kissei established a wholly owned U.S. subsidiary, Kissei U.S.A. Inc. (Hackensack, N.J.) to conduct U.S. clinical studies of Kissei's compounds. The subsidiary will have initial funds of $2.5 million and 4-5 employees, including president Fumiyasu Sato. ...